The Victoria BioBriefing, titled ‘The Capital Conversation: Funding Options for Life Sciences Companies’, will be held in Melbourne on Wednesday 19 August, at RSM Australia’s offices on Level 27, 120 Collins Street.
The event, which is being hosted by Endpoints Capital and RSM, will feature a panel discussion exploring how life sciences companies can balance dilutive and non-dilutive funding options (including venture capital, R&D finance, government grants and royalty monetisation) to manage risk and maintain momentum through key growth stages. The session will be moderated by Patrick Wales, Commercial Director at Endpoints Capital, alongside speakers from Avecho, Bio101, Tenmile and RSM Australia.
The event will be followed by a networking function.
